跳至主要内容
临床试验/CTRI/2020/04/024862
CTRI/2020/04/024862尚未招募4 期

Comparison of single dose versus double dose of mifepristone followed by misoprostol for termination of pregnancy in second trimester- A Randomised controlled trial

OT APPLICABLE0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
OT APPLICABLE

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • singleton intrauterine viable pregnancy
  • Gestational age 13-20 weeks
  • Women fulfilling the pre-requisites of Indian MTP Act, 1972

排除标准

  • 1.Prior two or more uterine surgeries (caesarean section or myomectomy)
  • 2. Having either taken MTP Pill from outside or self prescribed
  • 3. With inevitable or incomplete abortion
  • 4. Moderate or severe anaemia (Haemoglobin <8 gm /dL)
  • 5 .Heart disease, uncontrolled hypertension ( >140/90 mm Hg), diabetes mellitus, bronchial asthma, coagulation disorder and any other medical illness
  • 6 .Known hypersensitivity to mifepristone or misoprostol
  • 7.Haemodynamically unstable at the time of presentation
  • 8.Contra-indications to mifepristone or misoprostol: ectopic pregnancy, inherited porphyria, chronic adrenal failure, on immunosuppressants (corticosteroids).

研究者

发起方
OT APPLICABLE

相似试验